In yesterday’s Wall Street session, ReWalk Robotics Ltd. (NASDAQ:RWLK) shares traded at $0.87, down -0.03% from the previous session.
As of this writing, 1 analysts cover ReWalk Robotics Ltd. (NASDAQ:RWLK). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $3.00, we find $3.00. Given the previous closing price of $0.87, this indicates a potential upside of 244.83 percent. RWLK stock price is now 3.10% away from the 50-day moving average and -7.48% away from the 200-day moving average. The market capitalization of the company currently stands at $53.00M.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
There are 0 analysts who have given it a hold rating, whereas 1 have given it a buy rating. Brokers who have rated the stock have averaged $3.00 as their price target over the next twelve months.
With the price target reduced from $2.50 to $1.50, Barclays Downgraded its rating from Equal Weight to Underweight for ReWalk Robotics Ltd. (NASDAQ: RWLK)., while ‘Piper Jaffray’ rates the stock as ‘Overweight’.
In other news, Lind Global Fund II LP, 10% Owner bought 25,661 shares of the company’s stock on Jan 09. The stock was bought for $20,272 at an average price of $0.79. Upon completion of the transaction, the 10% Owner now directly owns 4,912,584 shares in the company, valued at $4.27 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 22, 10% Owner Lind Global Fund II LP bought 50,083 shares of the business’s stock. A total of $37,562 was incurred on buying the stock at an average price of $0.75. This leaves the insider owning 4,899,754 shares of the company worth $4.26 million. Insiders disposed of 36,734 shares of company stock worth roughly $31958.579999999998 over the past 1 year. A total of 12.81% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in RWLK stock. A new stake in ReWalk Robotics Ltd. shares was purchased by TWO SIGMA SECURITIES, LLC during the first quarter worth $40,000. VIRTU FINANCIAL LLC invested $12,000 in shares of RWLK during the first quarter. In total, there are 43 active investors with 9.30% ownership of the company’s stock.
Thursday morning saw ReWalk Robotics Ltd. (NASDAQ: RWLK) opened at $0.8580. During the past 12 months, ReWalk Robotics Ltd. has had a low of $0.70 and a high of $1.23. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 18.70, and a quick ratio of 17.90. The fifty day moving average price for RWLK is $0.8439 and a two-hundred day moving average price translates $0.9404 for the stock.
The latest earnings results from ReWalk Robotics Ltd. (NASDAQ: RWLK) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.07, missing analysts’ expectations of -$0.04 by -0.03. This compares to -$0.06 EPS in the same period last year. The company reported revenue of $0.89 million for the quarter, compared to $1.97 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -55.07 percent. For the current quarter, analysts expect RWLK to generate $1.8M in revenue.
ReWalk Robotics Ltd.(RWLK) Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
